America’s drug supply chains are not as reliable as they should be. Over the past year, the country has seen shortages of amoxicillin, cancer drugs, medications to treat ADHD, and lifesaving emergency drugs like atropine and epinephrine. These shortages can undermine medical care, endangering patient health and lives.
The severity of drug shortages has prompted the Biden administration and Congress to search for policy solutions, including stockpiles, changes to Medicare reimbursement, and more. But how should policymakers evaluate these options? Marta Wosińska shares a four-part test to assess potential solutions to drug shortages.
Most (63%) of the drugs in shortage are generic sterile injectables, Marta Wosińska finds.
More research and commentary
Boosting women’s financial inclusion in sub-Saharan Africa. Financial accounts, and particularly digital financial services, are key enablers of economic empowerment for women in sub-Saharan Africa. In a Foresight Africa viewpoint, Leora Klapper shares ways to expand access to digital finance.
Xi Jinping’s strategic deterrence. In October 2022, Chinese President Xi Jinping raised eyebrows with his pledge at the 20th Party Congress to “create a strong strategic deterrent force system.” Joel Wuthnow unpacks this phrase and discusses its implications.
The Brookings Institution,1775 Massachusetts Ave NW, Washington, DC 20036
The conclusions and recommendations of any Brookings publication are solely those of its author(s), and do not reflect the views of the Institution, its management, or its other scholars.
